Clinical trial

GDNF Gene Therapy for Parkinson's Disease

NCT04167540

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2020-04-01

PhasePHASE1

Study timeline

Study start (actual)2020-04-01Date precision: day

Registry last updated2025-09-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseunresolved

Interventions

AAV2-GDNFBIOLOGICAL

Sponsors & collaborators

Brain Neurotherapy Bio, Inc.lead sponsor

AskBio Inccollaborator

California Institute for Regenerative Medicine (CIRM)collaborator

Mapped research locations

San FranciscoCalifornia, United States1 ColumbusOhio, United States1 IrvineCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04167540 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.